Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.

Hamilton JG, Abdiwahab E, Edwards HM, Fang ML, Jdayani A, Breslau ES.

J Gen Intern Med. 2017 Mar;32(3):315-324. doi: 10.1007/s11606-016-3943-4. Epub 2016 Dec 19.

PMID:
27995427
2.

Theranostic barcoded nanoparticles for personalized cancer medicine.

Yaari Z, da Silva D, Zinger A, Goldman E, Kajal A, Tshuva R, Barak E, Dahan N, Hershkovitz D, Goldfeder M, Roitman JS, Schroeder A.

Nat Commun. 2016 Nov 10;7:13325. doi: 10.1038/ncomms13325.

3.
4.

Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility.

Ye BD, McGovern DP.

Expert Rev Clin Immunol. 2016 Oct;12(10):1091-107. doi: 10.1080/1744666X.2016.1184972. Epub 2016 Jun 15. Review.

PMID:
27156530
5.

Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw.

Olejniczak D, Dera P, Religioni U, Duda-Zalewska A, Deptała A.

Contemp Oncol (Pozn). 2016;20(1):80-5. doi: 10.5114/wo.2016.58504. Epub 2016 Mar 16.

6.

Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review.

Covolo L, Rubinelli S, Ceretti E, Gelatti U.

J Med Internet Res. 2015 Dec 14;17(12):e279. doi: 10.2196/jmir.4378. Review.

7.

Crowdsourced direct-to-consumer genomic analysis of a family quartet.

Corpas M, Valdivia-Granda W, Torres N, Greshake B, Coletta A, Knaus A, Harrison AP, Cariaso M, Moran F, Nielsen F, Swan D, Weiss Solís DY, Krawitz P, Schacherer F, Schols P, Yang H, Borry P, Glusman G, Robinson PN.

BMC Genomics. 2015 Nov 7;16:910. doi: 10.1186/s12864-015-1973-7.

8.

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.

Ko TM, Tsai CY, Chen SY, Chen KS, Yu KH, Chu CS, Huang CM, Wang CR, Weng CT, Yu CL, Hsieh SC, Tsai JC, Lai WT, Tsai WC, Yin GD, Ou TT, Cheng KH, Yen JH, Liou TL, Lin TH, Chen DY, Hsiao PJ, Weng MY, Chen YM, Chen CH, Liu MF, Yen HW, Lee JJ, Kuo MC, Wu CC, Hung SY, Luo SF, Yang YH, Chuang HP, Chou YC, Liao HT, Wang CW, Huang CL, Chang CS, Lee MT, Chen P, Wong CS, Chen CH, Wu JY, Chen YT, Shen CY; Taiwan Allopurinol-SCAR Consortium..

BMJ. 2015 Sep 23;351:h4848. doi: 10.1136/bmj.h4848.

9.

Genetics of Inflammatory Bowel Diseases.

McGovern DP, Kugathasan S, Cho JH.

Gastroenterology. 2015 Oct;149(5):1163-1176.e2. doi: 10.1053/j.gastro.2015.08.001. Epub 2015 Aug 7. Review.

10.

How do SNP ascertainment schemes and population demographics affect inferences about population history?

McTavish EJ, Hillis DM.

BMC Genomics. 2015 Apr 3;16:266. doi: 10.1186/s12864-015-1469-5.

11.

The audacity of interpretation: Protecting patients or piling on?

Angrist M.

Appl Transl Genom. 2014 Sep 1;3(3):68-69. No abstract available.

13.

Attitudes towards Social Networking and Sharing Behaviors among Consumers of Direct-to-Consumer Personal Genomics.

Lee SS, Vernez SL, Ormond KE, Granovetter M.

J Pers Med. 2013 Oct 14;3(4):275-87. doi: 10.3390/jpm3040275.

14.

Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR signaling.

Liu Y, Pham X, Zhang L, Chen PL, Burzynski G, McGaughey DM, He S, McGrath JA, Wolyniec P, Fallin MD, Pierce MS, McCallion AS, Pulver AE, Avramopoulos D, Valle D.

G3 (Bethesda). 2014 Nov 20;5(1):61-72. doi: 10.1534/g3.114.015636.

15.

Summarizing polygenic risks for complex diseases in a clinical whole-genome report.

Kong SW, Lee IH, Leshchiner I, Krier J, Kraft P, Rehm HL, Green RC, Kohane IS, MacRae CA; MedSeq Project..

Genet Med. 2015 Jul;17(7):536-44. doi: 10.1038/gim.2014.143. Epub 2014 Oct 23.

16.

Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics".

Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart MJ, Sidransky D, Soussan-Gutman L, Tziraki C.

J Natl Cancer Inst. 2014 Oct 7;106(12). pii: dju321. doi: 10.1093/jnci/dju321. Print 2014 Dec.

17.

Implementation and utilization of genetic testing in personalized medicine.

Abul-Husn NS, Owusu Obeng A, Sanderson SC, Gottesman O, Scott SA.

Pharmgenomics Pers Med. 2014 Aug 13;7:227-40. doi: 10.2147/PGPM.S48887. eCollection 2014. Review.

18.

Misuse (and abuse?) of the Concept of Empowerment.The Case of Online Offer of Predictive Direct-to-consumer Genetic Tests.

Covolo L, Rubinelli S, Orizio G, Gelatti U.

J Public Health Res. 2012 Feb 14;1(1):7-10. doi: 10.4081/jphr.2012.e3. eCollection 2012 Feb 17.

19.

Comparison of commercial genetic-testing services in Korea with 23andMe service.

Kim S, Eom KW, Cho CR, Um TH.

Biomed Res Int. 2014;2014:539151. doi: 10.1155/2014/539151. Epub 2014 Jun 25.

20.

Evaluating the accuracy of AIM panels at quantifying genome ancestry.

Pardo-Seco J, Martinón-Torres F, Salas A.

BMC Genomics. 2014 Jun 30;15:543. doi: 10.1186/1471-2164-15-543.

Supplemental Content

Support Center